Skip to main content
. 2011 Dec 14;45(1):66–75. doi: 10.1111/j.1365-2184.2011.00799.x

Table 2.

 The proliferative response of T and B cells to the different MSC sources. Table shows the results of: three BM MSCs in HS, three in LP and six in FBS; six CV in HS, three CV in LP and five CV in FBS; three AF in HS and eight in FBS. (IP) inhibition percentage of lymphocyte proliferation

CV MSCs HS CV MSCs PL CV MSCs FBS AF MSCs HS AF MSCs FBS BM MSCs HS BM MSCs PL BM MSCs FBS
Direct contact IP IP IP IP IP IP IP IP
 PB‐MNC 24% 35% 74% 20% 23% 47% 20% 24%
 CD4+ cells 31% 53% 65% 34% 35% 57% 24% 31%
 CD8+ cells 47% 39% 41% 52%
 CD19+ cells 31%
Transwell IP IP IP IP IP IP IP IP
 PB‐MNC 16% 16% 58% 33% 46% 28% 20% 30%
 CD4+ cells 68% 40% 28%
 CD8+ cells 64% 35% 44% 36% 33%
 CD19+ cells 40% 30%

AF, amniotic fluid; BM, bone marrow; CV, chorionic villi; HS, human allogeneic serum; MSCs, mesenchymal stem cells; PL, platelet lysate.